Mucosal Immunity
6
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before and After a Race
Neutralizing Power of Serum Antibodies - 2
To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children
Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study
Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)
Strategies for Enhancing Mucosal Immunity to Influenza Vaccine